Jupiter Asset Management’s Meridian Bioscience Inc VIVO Stock Holding History

Jupiter Asset Management’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-20,251	Closed	-$526K	–	660
2022 Q1	$526K	Buy	20,251 +1,693	+9%	+$40.3K	0.01%	442
2021 Q4	$373K	Hold	18,558	–	–	﹤0.01%	499
2021 Q3	$357K	Hold	18,558	–	–	﹤0.01%	504
2021 Q2	$411K	Hold	18,558	–	–	﹤0.01%	508
2021 Q1	$487K	Hold	18,558	–	–	﹤0.01%	488
2020 Q4	$347K	Hold	18,558	–	–	﹤0.01%	539
2020 Q3	$315K	Buy	+18,558	New	+$361K	﹤0.01%	535

Other funds holding VIVO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Impactive Capital New York City, New York $1.38B AUM 1.92% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VLKIM

Van Lanschot Kempen Investment Management Amsterdam, Netherlands $11.4B AUM 16.77% 1-Year Est. Return

Jupiter Asset Management's VIVO Position: Q2 2022 in Review

Jupiter Asset Management sold out of Meridian Bioscience Inc (VIVO) in Q2 2022, closing a stake of 20,251 shares — an estimated $526K sold.

Jupiter Asset Management first reported a position in VIVO in Q3 2020 and held it in 7 quarters. The position peaked at $526K in Q1 2022. 216 funds tracked by Wall St. Rank hold VIVO as of Q2 2022.

Jupiter Asset Management reported no remaining Meridian Bioscience Inc position as of Q2 2022 after selling out during the quarter.
Jupiter Asset Management sold 20,251 Meridian Bioscience Inc shares in Q2 2022, an estimated $526K.
Jupiter Asset Management first reported a position in Meridian Bioscience Inc in Q3 2020 and held it in 7 quarters.
Jupiter Asset Management's Meridian Bioscience Inc position peaked at $526K in Q1 2022.
216 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q2 2022.

Based on Jupiter Asset Management's 13F filing for Q2 2022, filed 10 Aug 2022.